3,008
Views
0
CrossRef citations to date
0
Altmetric
Article

Examining Risk Factors Accelerating Time-to-Chronic Obstructive Pulmonary Disease (COPD) Diagnosis among Asthma Patients

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 47-56 | Received 01 Sep 2021, Accepted 21 Dec 2021, Published online: 10 Jan 2022

References

  • World Health Organization (WHO). Asthma: key facts 2021. [Internet]. [cited 2021 Aug 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma.
  • Dharmage S, Perret J, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7(246):246.
  • Silva G, Sherrill D, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65. DOI:10.1378/chest.126.1.59
  • Tai A, Tran H, Roberts M, et al. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax. 2014;69(9):805–810. DOI:10.1136/thoraxjnl-2013-204815
  • Tagiyeva N, Devereux G, Fielding S, et al. Outcomes of childhood asthma and wheezy bronchitis: a 50-year cohort study. Am J Respir Crit Care Med. 2016;193(1):23–30. DOI:10.1164/rccm.201505-0870OC
  • Omori K, Iwamoto H, Yamane T, et al. Clinically remitted childhood asthma is associated with airflow obstruction in Middle-aged adults. Respirology. 2017;22(1):86–92. DOI:10.1111/resp.12860
  • Aanerud M, Carsin AE, Sunyer J, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J. 2015;45(3):635–643. Available from: DOI:10.1183/09031936.00055514
  • Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14–20. DOI:10.1136/thx.2008.112136
  • Asamoah-Boaheng M, Acheampong L, Tenkorang EY, et al. Association between early history of asthma and COPD diagnosis in later life: a systematic review and Meta-analysis. Int J Epidemiol. 2018;47(6):1865–1876. DOI:10.1093/ije/dyy207
  • To T, Zhu J, Larsen K, Canadian Respiratory Research Network, et al. Progression from asthma to chronic obstructive pulmonary disease is air pollution a risk factor? Am J Respir Crit Care Med. 2016;194(4):429–438. DOI:10.1164/rccm.201510-1932OC
  • To T, Zhu J, Gray N, et al. Asthma and chronic obstructive pulmonary disease overlap in women incidence and risk factors. Ann Am Thorac Soc. 2018;15(11):1304–1310. DOI:10.1513/AnnalsATS.201802-078OC
  • Bedouch P, Marra C, FitzGerald J, et al. Trends in asthma related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One. 2012;7(12):e50949– 8. DOI:10.1371/journal.pone.0050949
  • Population Data BC (PopData BC). Population data British Columbia [Internet]. 2021. Available from: https://www.popdata.bc.ca/.
  • Canadian Institute for Health Information (CIHI) [creator]. Discharge Abstract Database (Hospital Separations). V2. Population Data BC [publisher]. Data Extract. MOH 2020. [Internet]. British Columbia; 2019. Available from: http://www.popdata.bc.ca/data.
  • British Columbia Ministry of Health (BC MOH) [creator]. Medical Services Plan (MSP) Payment Information File. V2. Population Data BC [publisher]. Data Extract. MOH 2020. [Internet]. 2019. Available from: http://www.popdata.bc.ca/data.
  • British Columbia Ministry of Health (BC MOH) [creator]. PharmaNet. V2. Population Data BC [publisher]. Data Extract. Data Stewardship Committee 2020. [Internet]. 2020. Available from: http://www.popdata.bc.ca/data.
  • British Columbia Ministry of Health (BC MOH) [creator]. Consolidation File (MSP Registration & Premium Billing). V2. Population Data BC [publisher]. Data Extract. MOH(2020) [Internet]. 2020. Available from: http://www.popdata.bc.ca/data.
  • Population Data BC(PopData BC). Data available [Internet]. 2021. Available from: https://www.popdata.bc.ca/data.
  • Prosser R, Carleton B, Smith M. Identifying persons with treated asthma using administrative data via latent class modelling. Health Serv Res. 2008;43(2):733–754. DOI:10.1111/j.1475-6773.2007.00775.x
  • Chen W, FitzGerald JM, Sin DD, et al. Excess economic burden of comorbidities in COPD: a 15-year population-based study. Eur Respir J. 2017;50(1):1700393. [Internet]. Available from: DOI:10.1183/13993003.00393-2017
  • Friedman HS, Navaratnam P, McLaughlin J. Treatment and outcomes—adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma. 2010;47(9):994–1000. DOI:10.1080/02770903.2010.513076
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. DOI:10.1155/2015/217047
  • Korgaonkar S, BanahanIIIB, Pittman E, et al. Effect of depression on adherence to controller medications and healthcare resource utilization in asthma patients. Value Heal. 2018;21:S231. DOI:10.1016/j.jval.2018.04.1567
  • Engelkes M, Janssens HM, De Jongste JC, et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. Available from: DOI:10.1183/09031936.00075614
  • Núñez JE, Núñez E, Fácila L, et al. Prognostic value of charlson comorbidity index at 30 days and 1 year after acute myocardial infarction. Rev Esp Cardiol. 2004;57(9):842–849.
  • Kaplan A, Szefler SJ, Halpin DMG. Impact of comorbid conditions on asthmatic adults and children. NPJ Prim Care Respir Med. 2020;30(1):1–10.
  • Boulet L. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33(4):897–906. DOI:10.1183/09031936.00121308
  • Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872. Available from: DOI:10.1183/13993003.01872-2019
  • Ismaila A, Corriveau D, Vaillancourt J, et al. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin. 2014;30(7):1417–1425. DOI:10.1185/03007995.2014.908827
  • Firoozi F, Lemière C, Beauchesne MF, et al. Development and validation of database indexes of asthma severity and control. Thorax. 2007;62(7):581–587. DOI:10.1136/thx.2006.061572
  • Wang Y. Estimation of accelerated failure time models with random effects. 2006.
  • Faruk A. The comparison of proportional hazards and accelerated failure time models in analyzing the first birth interval survival data. J Phys Conf Ser. 2018;974(1):1–10.
  • Swindell WR. Accelerated failure time models provide a useful statistical framework for aging research. Exp Gerontol. 2009;44(3):190–200. DOI:10.1016/j.exger.2008.10.005
  • Abdul-Fatawu M. Accelerated failure time models: an application in insurance attrition. J Risk Manag Insur. 2020;24(2):1–18.
  • Ten Brinke A. Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol. 2008;8(1):63–69. DOI:10.1097/ACI.0b013e3282f3b5b5
  • Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–1200. DOI:10.1056/NEJM199810223391703
  • Ulrik C, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994;150(3):629–634. DOI:10.1164/ajrccm.150.3.8087330
  • Panizza J, James A, Ryan G, et al. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J. 2006;36(12):773–780. DOI:10.1111/j.1445-5994.2006.01214.x
  • Barnes PJ. Sex differences in chronic obstructive pulmonary Disease Mechanisms. Am J Respir Crit Care Med. 2016;193(8):813–824. DOI:10.1164/rccm.201512-2379ED
  • Wheaton A, Pleasants R, Croft J, et al. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome. J Asthma. 2016;53(7):720–731. DOI:10.3109/02770903.2016.1154072
  • Han MLK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–1184. DOI:10.1164/rccm.200704-553CC
  • Jain N, Thakkar M, Jain N, et al. Chronic obstructive pulmonary disease: does gender really matter? Lung India. 2011;28(4):258–262. DOI:10.4103/0970-2113.85686
  • Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–336. DOI:10.1056/NEJM200008033430504
  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention-update [Internet]. 2019 [cited 2021 Mar 3]. pp. 1–163. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf.
  • British Thoracic Society (BTS). British guideline on the management of asthma-A national clinical guideline. Revised edition. 2019.
  • Lougheed M, Lemière C, Dell SD, Canadian Thoracic Society Asthma Committee, et al. Canadian thoracic society asthma management continuum-2010 consensus summary for children six years of age and over, and adults. Can Respir J. 2010;17(1):15–24. DOI:10.1155/2010/827281
  • Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent Asthma: A Systematic Review and Meta-analysis. JAMA—J Am Med Assoc. 2018;319(14):1485–1496. DOI:10.1001/jama.2018.2769
  • Okelo SO, Butz AM, Sharma R, et al. Interventions to modify health care provider adherence to asthma guidelines: a systematic review. Pediatrics. 2013;132(3):517–534. DOI:10.1542/peds.2013-0779